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Saihan Borghjid1,2* and Richard David Feinman2Abstract
High fat feeding in rodents generally leads to obesity and insulin resistance whereas in humans this is only seen if
dietary carbohydrate is also high, the result of the anabolic effect of poor regulation of glucose and insulin. A
previous study of C57Bl/6 mice (Kennedy AR, et al.: Am J Physiol Endocrinol Metab (2007) 262 E1724-1739) appeared
to show the kind of beneficial effects of calorie restriction that is seen in humans but that diet was unusually low in
protein (5%). In the current study, we tested a zero-carbohydrate diet that had a higher protein content (20%). Mice
on the zero-carbohydrate diet, despite similar caloric intake, consistently gained more weight than animals
consuming standard chow, attaining a dramatic difference by week 16 (46.1 ± 1.38 g vs. 30.4 ± 1.00 g for the chow
group). Consistent with the obese phenotype, experimental mice had fatty livers and hearts as well as large fat
deposits in the abdomino-pelvic cavity, and showed impaired glucose clearance after intraperitoneal injection. In
sum, the response of mice to a carbohydrate-free diet was greater weight gain and metabolic disruptions in
distinction to the response in humans where low carbohydrate diets cause greater weight loss than isocaloric
controls. The results suggest that rodent models of obesity may be most valuable in the understanding of how
metabolic mechanisms can work in ways different from the effect in humans.Introduction
The high fat-fed mouse is a widely investigated model of
obesity, insulin-resistance and susceptibility to diabetes.
The C57Bl/6 strain, in particular, when subjected to high
dietary fat, shows increased consumption, increased effi-
ciency of fat storage (weight gained/calorie) and
becomes insulin resistant [1-4]. As a model of human
obesity and insulin resistance, however, it suffers from
the severe, if under-emphasized, limitation that high-fat
diets do not generally cause these conditions in humans
unless the diets are also high in carbohydrate. In fact,
carbohydrate-restricted diets (CRDs), even with high fat,
are the most effective therapy for diabetes and metabolic
syndrome; the greater the replacement of carbohydrate
with fat, the more effective the improvement (reviews:
[5-11]). In humans, it is low-carbohydrate diets that
most often demonstrate energy inefficiency [12] with re-
spect to lipogenesis and no diet is better for weight loss
although macronutrient effects on energy efficiency re-
main somewhat controversial.* Correspondence: sborghjid@molloy.edu
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distribution, and reproduction in any mediumThe rationale for CRDs is that glucose, directly or in-
directly through insulin and other hormones, has a cata-
lytic role in controlling other metabolites [10,13].
According to this principle, the observed effect of high
fat diets in mice would have to be explained by the pres-
ence of sufficient dietary carbohydrate or endogenous
insulin to maintain the anabolic state. An influential
paper that studied C57BL/6 mice under conditions of
zero carbohydrate [14] seemed to bear this out.
Kennedy, et al. [14] studied C57Bl/6 mice on a high
fat, ketogenic diet (KD) and showed that they displayed
all the characteristics of humans on a low-carbohydrate
diet: weight loss without caloric restriction, increased
energy expenditure, improved glucose tolerance, and
lowered serum insulin and leptin levels. The KD in Ken-
nedy, et al.. was 95% energy derived from fat and 5%
from protein. Such a diet is rather extreme compared to
a diet that might be consumed by a human even in an
experimental setting: first, 5% energy from protein is
very low and second, whereas there is no dietary re-
quirement for carbohydrate, in humans, the effects
attributed to the unique metabolic state associated with
carbohydrate restriction have not generally required
such an extreme fat/protein ratio. On the other hand, itd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Borghjid and Feinman Nutrition & Metabolism 2012, 9:69 Page 2 of 6
http://www.nutritionandmetabolism.com/content/9/1/69seemed possible that, because of the small brain size and
therefore limited requirements for glucose, very low
carbohydrate would be necessary to reproduce in a ro-
dent model the effect of CRDs seen in humans. We have
confirmed, in work to be published elsewhere, that mod-
erate lowering of carbohydrate had little effect on mice.
We therefore tried to repeat Kennedy’s experiment at
more traditional levels of protein while maintaining zero
carbohydrate. To our surprise, we observed the pheno-
type usually associated with the high fat-fed-mouse
model. Animals became obese and insulin-resistant and
gained substantially more weight per calorie than mice
fed normal chow. We describe here the results of these
experiments. The outcomes suggest that the results
found by Kennedy, et al. [14] were a consequence of the
low levels of dietary protein, possibly to the point of pro-
tein deprivation.Material and methods
Animals
Six-week old male C57Bl/6 mice (The Jackson Labora-
tory, Maine) were housed individually at 22°C on a 12-
hour light–dark cycle. Animals were allowed ad libitum
access to food, except when fasting overnight as
described later. Water was available to the animals at all
times. Applicable institutional and governmental regula-
tions concerning the ethical use of animals were fol-
lowed. All procedures were approved by State University
of New York Downstate Medical Center Animal Care
and Use Committee.Diets and diet trial
Twenty-four six-week-old male C57Bl/6 mice were accli-
mated to the laboratory conditions while consuming ad
libitum standard chow (Normal Chow #5001, LabDiet)
until they were nine weeks old; at ten weeks, mice are
generally considered adult. They were then randomly
assigned to two groups and were fed ad lib on either 1)
a zero-carbohydrate, ketogenic diet (Zero-CHO Group,
n = 12), or 2) continuation of the standard chow diet
(Chow Group, n = 11). The diet compositions were as
follows:
Chow Group: Normal Chow #5001, LabDiet (http://
www.labdiet.com/); 3.36 kcal/gm with % energy CHO:
fat:protein = 58:13.5:28.5.
Zero-CHO Group: Bio-Serv Inc. (http://www.bio-serv.
com/); 6.1 kcal/gm. The macronutrient composition: %
energy CHO:fat:protein = 0:80:20. This ketogenic diet
was supplemented with vitamin mix and mineral mix
that is complete in micronutrients. The fat composition
was Lard (401.0 g/kg) and Butter (142.5 g/kg).The above diets were maintained over a sixteen-week
trial period. During the trial period, body weights and
ad libitum food intake were measured twice weekly. The
food intake measurements were corrected for spillage.
Physical activity was not monitored but by inspection, as
expected, was reduced as animals got fatter.
Glucose tolerance tests
At the twelfth week of the trial period, all twenty-three
mice were fasted overnight and were injected with glu-
cose (2 gram/Kg body weight) intraperitoneally. Tail
blood was collected at 0, 15, 30, 60, 120, and 180 min.
Blood glucose concentrations were measured using a
glucometer (Elite, Bayer).
Tissue samples
Retro-orbital Bleeding: standard heparinized micro-
hematocrit capillary tubes were used for blood collection
under anesthesia. The blood was withdrawn after over-
night fasting, and the amount of blood withdrawn was
no more than 1% of the animal’s body weight (e.g., 0.3 ml
from a 30gm adult mouse).
Terminal Bleeding and Necropsy: after overnight fast-
ing, mice were asphyxiated to unconsciousness using
CO2 and blood was withdrawn by cardiac puncture. Tis-
sues (brain, heart, liver, skeletal muscle and fat) were
collected and snap frozen in liquid nitrogen before storage
at −80°C.
Blood serum from retro-orbital bleeding and terminal
bleeding was separated by centrifugation at 5000 rpm
for 20 min and was stored at −80°C.
Enzyme-linked immunoSorbent assay
Fasting mouse serum was analyzed using Enzyme-
Linked ImmunoSorbent Assay (ELISA). The quantitative
determination of serum leptin was done using Mouse
Leptin ELISA Kit (Cat #90030, Crystal Chem Inc., IL).
Statistical analysis
Data are presented as means ± standard error. Statistical
significance between groups was assessed by 1) unpaired
Student t-Test; 2) one-way ANOVA and Student-
Newman-Keuls post hoc analysis; 3) two-way ANOVA.
Statistical significance was taken as P< 0.05.
Results
Food intake and body weight
In the first week of the trial period, mice introduced to
the zero carbohydrate diet (Zero-CHO group; % CHO:
fat:protein = 0:80:20) consumed more calories than mice
on the standard chow diet (Chow group; % CHO:fat:pro-
tein = 58:13.5:28.5). In this period, the Zero-CHO group
consumed 105 Kcal compared to 94 Kcal for the Chow
group. Over the course of four weeks, differences in the
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from week four onward, mice in the Zero-CHO group
and Chow group consumed roughly the same total cal-
ories weekly (P = 0.38). This pattern of food intake con-
tinued throughout the diet trial, which lasted sixteen
weeks (Inset to Figure 1).
The mean body weights for each group are shown in
Figure 1. Despite the similarity in caloric intake, mice on
the Zero-CHO diet consistently gained more weight
than mice on standard chow throughout the sixteen-
week trial period (P< 0.0001). By week 16, this led to
dramatically heavier body weights for mice consuming
the Zero-CHO diet (46.1 ± 1.38 g) compared to only
30.4 ± 1.00 g for the Chow group. Consistent with the
obese phenotype, mice on Zero-CHO diet had fatty
livers and hearts, and large amounts of fat deposition in
the abdomino-pelvic cavity (data not shown).
Impaired glucose clearance
Glucose tolerance tests revealed impaired glucose clear-
ance in mice fed Zero-CHO diet (Figure 2). Zero-CHOFigure 1 Average weight as a function of time on the indicated diet.
week trial period from diet groups: Chow group (green), Zero-CHO group
body weights of the mice on a ketogenic diet (% energy ratio of CHO:fat:p
less weight than chow-fed mice and whose body weights were similar to
chow intake [2]. Statistical differences among the means were determined
for body weight (P< 0.0001).mice had significantly higher fasting glucose levels com-
pared to the Chow fed group at week 12 (Zero-CHO group
138.9±6.62 mg/dL vs. Chow group 107.1±4.30 mg/dL;
P< 0.0009). Zero-CHO mice showed significantly higher
levels of blood glucose at all time points compared to the
Chow group following intraperitoneal glucose injection
(P= 0.02). Three hours after glucose injection, Zero-CHO
group blood glucose was 91.4± 22.95 mg/dL higher than
baseline (0 time), more than two-fold increase over the in-
crease of the Chow group (43.8± 12.20 mg/dL).Leptin
Fasting blood leptin levels of male C57Bl/6 mice fed the
Zero-CHO and standard Chow diets were measured in a
separate study shown in Figure 3. The blood leptin con-
centration closely correlated with individual mouse’s
body weight (R = 0.93). A close correlation between
Zero-CHO diet induced obesity and elevation of blood
leptin levels is seen in the fact that all of the Zero-CHO
mice gained more weight and exhibited higher fastingBody weight and calorie intake (Inset) in male C57Bl/6 mice during 16-
(red). Values are mean± standard error. The blue dashed line shows
rotein = 0:95:5) in the experiment reported by Kennedy that gained
calorie restricted (CR) mice that had consumed 65 % of their average
by one-way ANOVA for calorie intake (P = 0.38) and two-way ANOVA
Figure 2 Glucose tolerance tests on male C57Bl/6 mice fed Zero-CHO and standard Chow diets. Glucose tolerance tests were
administered at week 12 of the diet trial. Blood glucose concentrations are shown at 0 min, 30 min, 60 min, and 180 min time points: Chow
group (blue), Zero-CHO group (red). Statistical differences among the means were determined using unpaired Student t-Test at each time point
(P<0.0009). The inset to the figure shows that every animal in the zero-CHO group showed decreased glucose clearance.
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(Figure 3).
Discussion
Because of the access to intracellular downstream signal-
ing pathways, animal models provide biological informa-
tion that is not generally accessible in human. The major
caveat in the use of animal models is obviously that dif-
ferent animals have different metabolic responses. This
is especially true in diet where humans are omnivores
and have substantial flexibility in response to changing
macronutrient composition. The “natural” diet of the
mouse is dependent on strain but is generally high in
carbohydrate and normal is probably operationally
defined as laboratory chow. In the context of public
health, one must be circumspect in generalizing from
the effects in rodents where high-fat diets have an effect
that appears to be far less sensitive to carbohydrates
than that seen in humans. In particular, low fat recom-
mendations continue to fail in large trials while lowcarbohydrate diets, even if high in fat, are more effective
in isocaloric comparisons for however long they are
compared.
Remarkable in the current study is the non-linear cal-
oric response. The mice in this study showed a substan-
tially greater increase in fat per calorie consumed than
predicted by the standard “calorie-is-a-calorie” idea fre-
quently invoked in nutrition. This has been reported
previously in the literature in C57Bl/6 mice on high-fat
diets [15]. This is in distinction to the effect seen in
humans where it is frequently found that, on low-
carbohydrate diets less fat is gained per calorie, referred
to popularly as a “metabolic advantage [16],” that is, the
controlling variable is carbohydrate rather than fat.
While such non-linear energy efficiency was once
claimed to violate laws of thermodynamics, theoretical
analysis shows no contradiction from physical law and
there are now numerous examples in humans and ani-
mal models [12,17]. Animal models of the type studied
here make it clear that energy balance is not as assumed.
Figure 3 Correlation of blood leptin level and body weight in male C57Bl/6 mice. Individual serum leptin concentration of Zero-CHO fed
mice (red; n = 10, at 55-week) and Chow fed mice (blue; n = 4, at 57-week). Line represents exponential fit to the plotted points.
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level of carbohydrate rather than on fat as seen here in
mice emphasizes the need to attend to differences in
species.
Differential effect of macronutrients, in this case,
saturated vs. unsaturated fatty acids was shown by
Wen, et al.. [1] who found that the saturated fatty acid
palmitate, but not oleate, induced activation of the
NLRP3-ASC inflammasome, raising caspase-1, IL-1b
and IL-18 production and this impaired insulin signal-
ing in several tissues in culture, reducing glucose toler-
ance and insulin sensitivity similar to results reported
here. However, in humans, Forsythe, et al. showed that
compared to the response to a low fat diet (LFD) (%
CHO:fat:protein = 56:24:20) a low-carbohydrate, high-fat
diet (% CHO:fat:protein = 12:59:28) with three times the
amount of saturated fat as the LFD led to an increased
proportion of serum total n-6 PUFA, mainly attributed
to a marked increase in arachidonate (20:4n-6). The
n-6/n-3 and arachidonic/eicosapentaenoic acid ratio also
increased sharply. Both diets significantly decreased the
concentration of several serum inflammatory markers, but
there was an overall greater anti-inflammatory effectassociated with the very low carbohydrate ketogenic diet,
as evidenced by greater decreases in TNF-alpha, and nu-
merous other markers. Increased 20:4n-6 and the ratios of
20:4n-6/20:5n-3 and n-6/n-3 are commonly viewed as
pro-inflammatory but, unexpectedly, were consistently in-
versely associated with responses in inflammatory proteins
[18,19].Conclusions
At least in the widely used C57Bl/6 mouse, high-fat
feeding, even in the absence of dietary carbohydrate,
leads to obesity and an associated increase in leptin
levels as well as distinct insulin resistance. This is in dis-
tinction to the results of Kennedy, et al. [14] whose
ketogenic diet in C57Bl/6 mice more closely resembled
the beneficial state found in humans on carbohydrate-
restricted diets. The likely explanation is that that diet
was protein-deficient and the mice were not in a normal
metabolic state. In the end, the great power of modern
molecular biology in rodent models may provide more
evidence as to the mechanisms by which humans are
different from rodents in the response to diet.
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